Company

Formation Bio

AI-native pharmaceutical company that acquires clinical-stage drug candidates and uses AI systems to run drug development and clinical trials more efficiently

AIHealthcare & Biotech

People

Ben Liufounder

Funding History

Oct 28, 2026

Formation Bio raised a $600M drug development fund to finance clinical-stage drug assets, providing both capital and AI-enabled development capabilities to biotech companies.

600M

News

Interviews (1)

Formation Bio raises $600M drug development fund to solve the clinical trial bottleneck AI is about to make critical

28 Oct 2026